Seventeen Companies Accepted During 1st-Round Vetting for Rocky Mountain Life Science Investor Conference

Share Article

Organizers of the Inaugural Rocky Mountain Life Science Investor Conference (RMLIC) have chosen 17 of the thirty presenting companies in first-round vetting for the September 17th event at the Ritz Carlton in Denver. The conference will showcase the most innovative private and public life science companies in a multi-state region to a targeted audience of national investors.

In its selection committee's first round, the Rocky Mountain Life Science Investor Conference (RMLIC) has chosen 17 of thirty regional companies to showcase their technologies on Thursday, September 17th at the Ritz Carlton in Denver. The announcement is made by John Collar, President & CEO of the Colorado Bioscience Association (CBSA), whose organization is co-hosting the inaugural event with the Arizona BioIndustry Organization (AZBio), along with regional industry partners in Montana, Utah, and New Mexico.

Companies selected in first-round vetting for the RMLIC include:

  • Apoplogic - Aurora, CO -
  • BioAmps - Aurora, CO -
  • Biodesix - Broomfield, CO -
  • BiOptix - Boulder, CO -
  • Coherex - Salt Lake City, UT -
  • GlobeImmune - Louisville, CO -
  • High Throughput Genomics - Tucson, AZ -
  • Inviragen - Fort Collins, CO -
  • Kinetic Muscles - Tempe, AZ -
  • Lineagen - Salt Lake City, UT -
  • Medivance - Louisville, CO -
  • miRagen - Boulder, CO -
  • Myocept -Lafayette, CO -
  • Regenesis - Scottsdale, AZ -
  • ThermImage - Salt Lake City, UT -
  • ValvExchange - Aurora, CO -
  • Vital Access - Salt Lake City, UT -

"The Rocky Mountain Life Science Investor Conference is the region's first and only life science investor conference and will bring together leading investors, emerging companies and senior executives to cultivate partnerships within the industry," said Collar. "The conference will be an impressive representation of the region's efforts in the life science arena."

Thirty of the Rocky Mountain Region's most innovative private and public life science companies will ultimately be selected to present to a targeted audience of national investors. The selected presenting companies will also gain access to business development professionals from national pharmaceutical, medical device and biotechnology companies during the conference.

"Given the explosive growth of biotech and medical device companies in the Rocky Mountain region in the last half-dozen years, this conference will provide an excellent opportunity for leading companies to describe their work to interested investors. Both are likely to be surprised at the opportunities for mutual interest," says Chris Christoffersen, Partner, Morgenthaler Ventures, who serves on the RMLIC selection committee.

"We believe this region has a variety of exciting bioscience companies and this conference provides a great new opportunity for them to reach the broader life-science investment community," says Bob Eaton, AZBio president. "AZBio is pleased to co-host this event with the Colorado BioScience Association and provide a forum to showcase the potential of some of these intriguing firms.

To learn more about the conference, and the region's success, please visit the conference website at

About Arizona BioIndustry Association

The Arizona BioIndustry Association is a not-for-profit, 501(c)(6) trade association that seeks to unify, empower and advance its member organizations, allowing them to benefit individually by acting collectively. AZBio strives to enhance the environment that makes Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for the Biotechnology Industry Organization (BIO), the preeminent trade association for the biotechnology industry in the United States. For more information, visit

About Colorado BioScience Association

CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, CBSA actively works to promote the growth of the industry by working for a better business environment, grow the state's biotech workforce, fight for policies that support a strong bioscience industry in the state and speak with a single voice on behalf of the industry. For more information, visit


April Giles, Vice President, Administration & Operations, Colorado BioScience Association, 303-592-4071

Maggie Chamberlin Holben, APR, Absolutely Public Relations - - 303-984-9801

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website